Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Enrolling by invitation1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

enrolling_by_invitation133%
not_yet_recruiting133%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
enrolling_by_invitationnot_applicable

Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients With Chronic Pain

NCT06407115
not_yet_recruiting

Clinical Safety Guidelines for Managing Distal Shoe Complications

NCT07410442
unknownphase_4

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

NCT02130973

Clinical Trials (3)

Showing 3 of 3 trials
NCT06407115Not Applicable

Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients With Chronic Pain

Enrolling By Invitation
NCT07410442

Clinical Safety Guidelines for Managing Distal Shoe Complications

Not Yet Recruiting
NCT02130973Phase 4

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3